Skip to main content
Premium Trial:

Request an Annual Quote

Freenome: Lance Baldo 

Freenome has hired Lance Baldo as its chief medical officer. Baldo has more than 20 years of clinical, product development, and operational experience and will be responsible for overseeing all aspects of Freenome's clinical development, medical and scientific affairs, and quality and regulatory teams with an initial focus on expanding the firm's capabilities beyond colorectal cancer.

Most recently, Baldo served as CMO of Adaptive Biotechnologies. Prior to that he held numerous roles with the Roche Group and its affiliates, including as senior VP and head of US medical affairs at Genentech. He holds an MD from the University of Connecticut School of Medicine and a BA in biology from Johns Hopkins University.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.